Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
Despite the emergence of new groups of drugs for the treatment of type 2 diabetes mellitus (DM2), the issue of optimal adherence to treatment remains of interest.The aim of this study was to investigate the factors that influence the adherence to treatment with sodium glucose co-transporter type 2 i...
Saved in:
| Main Authors: | D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2020-10-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/2978 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Post-Transurethral Resection of Bladder Tumor Infection and Prognosis
by: Nobutaka Nishimura, et al.
Published: (2025-07-01) -
New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it
by: E. V. Kovalenko, et al.
Published: (2022-10-01) -
A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors
by: D. P. Golubovskaya, et al.
Published: (2022-11-01) -
Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01) -
Empagliflozin: a path from glycemic control to reduced cardiovascular mortality and heart failure-related hospitalizations
by: N. R. Khasanov
Published: (2022-02-01)